Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scilex Holding (SCLX) Asset Writedowns and Impairment (2024)

Scilex Holding has reported Asset Writedowns and Impairment over the past 1 years, most recently at $14.8 million for Q4 2024.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $14.8 million in Q4 2024 year-over-year; TTM through Dec 2024 was $17.3 million, a N/A change, with the full-year FY2024 number at $17.3 million, changed N/A from a year prior.
  • Asset Writedowns and Impairment reached $14.8 million in Q4 2024 per SCLX's latest filing, up from $1.2 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $14.8 million in Q4 2024, with the low at $1.2 million in Q2 2024.